First Solar Posts Record $1.0 B Q1 Net Sales on 31% Module Volume Surge

Why It Matters

First Solar’s record quarter validates the strategic bet on U.S.‑centric manufacturing and the Section 45X tax credit, both of which are reshaping the solar industry’s cost structure. For CRO and operations leaders, the company’s ability to drive a 31% increase in module volume while expanding gross margin demonstrates how supply‑chain resilience can translate into revenue growth even amid policy uncertainty and international headwinds. The firm’s growing backlog—$14.4 billion in contracted sales through 2030—offers a rare glimpse of long‑term demand visibility in a sector often subject to rapid price swings. As other solar manufacturers grapple with trade disputes and fluctuating ASPs, First Solar’s disciplined booking strategy and near‑full U.S. plant utilization provide a template for balancing growth with risk mitigation.

Key Takeaways

• First Solar posted $1.0 billion Q1 net sales, a 24% YoY increase
• Module production rose 31% to 4.3 GW, with U.S. utilization at ~96%
• Gross margin expanded to 47%, up six points from 2025
• Adjusted EBITDA hit $520 million, beating the upper end of guidance
• Backlog now stands at 47.9 GW, valued at $14.4 billion

Pulse Analysis

First Solar’s Q1 performance underscores a broader shift in the renewable‑energy sector toward domestic manufacturing as a hedge against geopolitical risk. The company’s near‑full utilization of U.S. assets reflects the effectiveness of the Section 45X tax credit, which incentivizes American‑made solar modules and has spurred a wave of capacity investments. This policy‑driven model contrasts sharply with peers that remain heavily reliant on offshore production, exposing them to tariff volatility and supply‑chain disruptions.

The 31% jump in module volume signals that First Solar’s thin‑film technology is gaining traction, particularly in utility‑scale projects where land‑use efficiency and long‑term reliability are prized. However, the lower average selling price in India highlights a pricing dilemma: scaling volume in price‑sensitive markets can erode margins unless offset by technology‑driven premium pricing, such as the upcoming CURE adjusters. The successful launch of CURE at Perrysburg positions the firm to capture higher‑margin revenue streams in 2027‑28, potentially offsetting current ASP compression.

Looking forward, the company’s disciplined booking approach—waiting for policy clarity before locking in U.S. contracts—may temper short‑term growth but preserves pricing power. Investors will watch the Section 232 IP investigation and FEOP rulemaking closely; any adverse outcomes could tighten the U.S. market and shift demand back to lower‑cost overseas producers. In that scenario, First Solar’s robust cash balance and diversified backlog provide a cushion, while its strategic focus on domestic capacity and technology differentiation could set a new benchmark for supply‑chain resilience in the solar industry.